Cargando…
Advanced glycation end products in diabetic retinopathy and phytochemical therapy
Advanced glycation end products (AGEs) are generated by the nonenzymatic glycation of proteins or lipids. Diabetic retinopathy (DR) is one common complication in patients with diabetes. The accumulation of AGEs in retinal cells is strongly associated with the development of DR. AGEs can induce the b...
Autores principales: | Kang, Qingzheng, Dai, Haiyu, Jiang, Suwei, Yu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716030/ https://www.ncbi.nlm.nih.gov/pubmed/36466410 http://dx.doi.org/10.3389/fnut.2022.1037186 |
Ejemplares similares
-
Inhibition of Advanced Glycation End Products in Yogurt by Lotus Seedpod Oligomeric Procyanidin
por: Feng, Nianjie, et al.
Publicado: (2021) -
Fluorescent advanced glycation end products in type 2 diabetes and its association with diabetes duration, hemoglobin A1c, and diabetic complications
por: Liu, Rui, et al.
Publicado: (2022) -
Berberine suppresses advanced glycation end products‐associated diabetic retinopathy in hyperglycemic mice
por: Wang, Ning, et al.
Publicado: (2021) -
Debate: Could the litchi pericarp oligomeric procyanidins bioconverted by Lactobacillus plantarum increase the inhibitory capacity on advanced glycation end products?
por: Feng, Nianjie, et al.
Publicado: (2022) -
Advanced glycation end products and diabetes and other metabolic indicators
por: Jiang, Tian, et al.
Publicado: (2022)